Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

CUSIP: 05337M104

Q2 2019 13F Holders as of 30 Jun 2019

Security type / class
Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Total 13F shares
19,348,881
Total 13F value
$55,916,464
Holder snapshot 6 signals
Share change
-258,183
SEC-reported price per share
$2.89
Number of holders
41
Value change
-$532,703
Number of buys
17
Number of sells
16
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
98,762,388

Security key

05337M104

Report period

Q2 2019

Institutions

41

Top holders

10

AVDL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2019 Previous quarter: Q1 2019 AVADEL PHARMACEUTICALS PLC SEC filings AVADEL PHARMACEUTICALS PLC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BRANDES INVESTMENT PARTNE...
Disclosed value leader
BRANDES INVESTMENT PARTNE...
Comparable rows
15/15
Latest evidence
31 Mar 2019
13F Lead comparable stake: 7.1% Showing 1-6 of 15 holder rows.

Quick read

BRANDES INVESTMENT PARTNERS, LP leads the comparable SEC ownership view at 7.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BRANDES INVESTMENT PARTNERS, LP's linked filing trail.
Comparable ownership Top 5
BRANDES INVESTMENT PARTNERS, LP 7.1%
Broadfin Capital, LLC 3.1%
DEERFIELD MANAGEMENT COMPANY, L.P. 2.8%
BROWN CAPITAL MANAGEMENT LLC 1.4%
ACADIAN ASSET MANAGEMENT LLC 0.85%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BRANDES INVESTMENT PARTNERS, LP
13F
Company
13F
7.1%
$10,157,000
7,052,720 shares
 — 31 Mar 2019
Broadfin Capital, LLC
13F
Company
13F
3.1%
$4,468,000
3,102,673 shares
 — 31 Mar 2019
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
2.8%
$3,920,000
2,722,241 shares
 — 31 Mar 2019
BROWN CAPITAL MANAGEMENT LLC
13F
Company
13F
1.4%
$2,016,000
1,400,007 shares
 — 31 Mar 2019
ACADIAN ASSET MANAGEMENT LLC
13F
Company
13F
0.85%
$1,217,000
843,975 shares
 — 31 Mar 2019
Tekla Capital Management LLC
13F
Company
13F
0.82%
$1,173,000
814,588 shares
 — 31 Mar 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
41
Shares
19,348,881
Rows available
41
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
39
Q2 2019 holders
41
Holder diff
2
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 value Q2 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .